Kerry Whalen

She is an experienced oncology research and drug development professional with a strong background in preclinical development, biologics, discovery biology, translational biology, genetics, and microbiology. She currently works as Senior Director of Preclinical and Early Development for Biologics at Cullinan Oncology. Previously, she held senior research and leadership roles at Tarveda Therapeutics and AVEO Oncology, focusing on discovery and translational biology. Her earlier experience includes postdoctoral research at Pfizer and graduate research at Tufts University, where she earned her PhD in Genetics.